Georgia's Online Cancer Information Center

Mary Alice Moses: “[I wanted to] increase the number of women who participated in clinical trials.” MaryAlice Moses

Mary Alice Moses

“[I wanted to] increase the number of women who participated in clinical trials.”

When Austell, Ga resident MaryAlice Moses was notified of an opportunity to participate in two cancer prevention clinical trials, she knew it was the right thing to do.

Even though MaryAlice did not have cancer, she wanted a chance to contribute to cancer research. She was aware that the clinical trials presented to her would be used to identify risk factors for developing breast and ovarian cancers.

So, MaryAlice decided to enroll in both "The Sister Study: A Study of the Environmental and Genetic Risk Factors for Breast Cancer" and in the "North Carolina Ovarian Cancer Study." These studies involve individuals who have cancer as well as those who have never had cancer – all to help determine the factors that put a person at higher risk for developing a certain type of cancer.

MaryAlice admits, she was at first skeptical about the intent of clinical trials.

So she conducted some research of her own to learn about the meaning and purposes of clinical trials. Once she learned about their significance in the cancer community, her attitude changed.

MaryAlice states that she got involved with clinical trials in order to "assist in the findings regarding data on African American women and to increase the number of women who participate in clinical trials."

Back to Survivors' Voices


Alabama embryo ruling may have devastating effect on cancer patients

Cancer patients concerned about their fertility and oncologists are expressing shock and anxiety about the recent ruling by the Alabama Supreme Court that frozen embryos are considered children under the law.


Georgia CORE is expanding our team

Georgia CORE is looking to fill the position of a part-time Chief Medical Officer.


Georgia CORE awards Cancer Research Fund grant to two teams

Georgia CORE has awarded two teams a Collaborative Cancer Research Seed Grant from the Georgia Cancer Research Fund.